Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Pfizer
(NY:
PFE
)
27.70
+0.52 (+1.91%)
Official Closing Price
Updated: 4:10 PM EDT, May 2, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Pfizer
< Previous
1
2
...
9
10
11
12
13
14
15
16
17
...
99
100
Next >
Anthropic's Claude Chatbot Gets an Upgrade with Image Analysis, Challenging Google and OpenAI
January 17, 2024
Anthropic's Chatbot Claude Set to Analyze Images, Rivaling Google Bard and ChatGPT. This new feature in Claude could elevate user interaction, offering tasks like image comparison and artwork...
Via
Benzinga
Why Pfizer Stock Is a Fantastic Pharma Comeback Candidate
January 17, 2024
If Pfizer can seize a piece of the obesity-drug pie, PFE stock has the potential to rebound sharply this year.
Via
InvestorPlace
GSK Cuts More Stake In Its Spun-Off Consumer-Healthcare Business Haleon, Raises Over £900M
January 17, 2024
GSK sells 300M shares in Haleon at £326/share, raising £978M. GSK to retain 4.2% stake.
Via
Benzinga
Cathie Wood's Ark Invest Liquidates $15.8M Worth Of ProShares Bitcoin Strategy ETF Units
January 16, 2024
On Tuesday, Cathie Wood-led Ark Invest made a significant move by selling $15.84 million worth of ProShares Bitcoin Strategy ETF (NYSE:BITO) units.
Via
Benzinga
Topics
ETFs
10 Health Care Stocks With Whale Alerts In Today's Session
January 16, 2024
Via
Benzinga
Is Pfizer Stock a Buy in 2024?
January 14, 2024
The drugmaker appears to be a top value play, but execution will be key.
Via
The Motley Fool
7 Incredible Reasons to Buy Pfizer Stock Right Now
January 13, 2024
The company's work should pay off eventually.
Via
The Motley Fool
10 High-Yield Dividend Stocks for Huge Amounts of Income
January 16, 2024
All 10 of these dividend stocks have yields above 4%.
Via
The Motley Fool
Financial Relief For Medicare Patients: Part D Overhaul Caps Out-of-Pocket Drug Cost Limits
January 16, 2024
In 2024, the Inflation Reduction Act limits out-of-pocket drug costs to $3,300 annually, with further reductions to $2,000 in 2025.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Infosys Stock Shows Market Leadership; Shares Jumped Recently
January 16, 2024
A Relative Strength Rating upgrade for Infosys stock shows improving technical performance.
Via
Investor's Business Daily
Are You Kidding Me? 3 Meme Stocks You Should Have Already Sold
January 15, 2024
Be sure to sell these meme stocks as they represent fundamentally weak businesses that will continue to erode in value.
Via
InvestorPlace
I'm Passing on Pfizer Stock in 2024. Here's Why.
January 15, 2024
Pfizer's best days might be behind it as demand for its COVID-19 products hits a wall.
Via
The Motley Fool
Exposures
COVID-19
2 Red Flags That Could Sink Pfizer in 2024
January 13, 2024
Pfizer shares dropped more than 40% last year.
Via
The Motley Fool
Decoding Pfizer's Options Activity: What's the Big Picture?
January 10, 2024
Via
Benzinga
Hidden High-Yielders: 7 Overlooked Stocks with Attractive Dividends
January 14, 2024
Here are seven overlooked high-yield dividend stocks for you to consider no matter where interest rates at the end of 2024.
Via
InvestorPlace
Why Big Pharma Led By Merck, Sanofi, Teva Are Pouring Billions Into A New Immunology Space
January 12, 2024
The companies are working on blocking TL1A, a protein tied to inflammatory bowel disease.
Via
Investor's Business Daily
Beat Inflation With These 3 High-Yielding Dividend Stocks In Health Care Sector From Wall Street's Most Accurate Analysts
January 12, 2024
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
3 Megatrend Stocks that Will Revolutionize Your Portfolio
January 11, 2024
Consider these powerhouse stocks for likely significant capital appreciation, growth, and rewards for your portfolio.
Via
InvestorPlace
Dividend Dynasty: 7 High-Yield Stocks for Long-Term Wealth Accumulation
January 11, 2024
Navigate 'Dividend Dynasty': Uncover seven high-yield stocks combining stable dividends with sustainable growth strategies.
Via
InvestorPlace
Large Drugmakers Show Enthusiasm To Embrace $100B Obesity Market, Despite Novo And Lilly's Dominance
January 11, 2024
Pharmaceutical companies, including Amgen Inc (NASDAQ: AMGN) and Pfizer Inc (NYSE: PFE), are strategically positioning themselves to tap into the
Via
Benzinga
FDA Allows Importing Unapproved But Essential Syphilis Treatment Amid Shortage Of Pfizer's Antibiotic
January 11, 2024
FDA collaborates with Laboratoires Delbert to address syphilis treatment shortage. Learn about the temporary import of Extencilline, an alternative to Bicillin. Shortage expected until June.
Via
Benzinga
Exposures
Product Safety
Pfizer’s 2024 Outlook: Is PFE Stock Poised for a Major Rebound?
January 11, 2024
Pfizer is certainly a company that will need to continue to battle headwinds moving forward, but is PFE stock worth a buy?
Via
InvestorPlace
A Bull Market Is Coming: 2 Magnificent Stocks Down More Than 50% to Buy Right Now
January 11, 2024
These market leaders offer great long-term prospects.
Via
The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
January 10, 2024
Via
Benzinga
Current Analysis: Pfizer
January 09, 2024
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion. Over the past year, Pfizer's share price decreased about 39.25% from $48.39 to $29.39 as of Tuesday’s...
Via
Talk Markets
Your Path to Wealth: 3 Stocks Predicted to Double Your Investment by 2025
January 09, 2024
Unveil three standout companies set to double investments by 2025 with groundbreaking strategies in tech and healthcare.
Via
InvestorPlace
BioNTech Prepares To Be Commercial Ready By 2025, Revenue Growth Expected To Return In 2025
January 09, 2024
On Tuesday, BioNTech SE (NASDAQ: BNTX) outlined priorities at the Annual J.P.
Via
Benzinga
2024 Marks a New Era Of Pharmaceutical Innovation
January 09, 2024
With Covid-19 finally fading into history, the Covid-19 heroes, namely Moderna Inc (NASDAQ: MRNA) and Pfizer Inc (NYSE: PFE) were forced to redefine their business focus last year, and so, they turned...
Via
Benzinga
Exposures
COVID-19
Artificial Intelligence: OurCrowd's 20 Verticals For Investors To Watch
January 09, 2024
AI seems to be the world’s fastest-growing investment sector. The rush of interest in ChatGPT and similar generative AI platforms has triggered a global wave of funding for the new technology.
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Pfizer's Aggressive Stance In Obesity Drugs: CEO Albert Bourla Confirms Bold Bet Despite Prior Drug Hurdles
January 09, 2024
Monday, at the JP Morgan Healthcare Conference, Pfizer Inc (NYSE: PFE) CEO Albert Bourla expressed that the company is determined to move forward in the burgeoning
Via
Benzinga
< Previous
1
2
...
9
10
11
12
13
14
15
16
17
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.